SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease

Mijuskovic, M; Saunders, EJ; Leongamornlert, DA; Wakerell, S; Whitmore, I; Dadaev, T; Cieza-Borrella, C; Govindasami, K; Brook, MN; Haiman, CA; et al. Mijuskovic, M; Saunders, EJ; Leongamornlert, DA; Wakerell, S; Whitmore, I; Dadaev, T; Cieza-Borrella, C; Govindasami, K; Brook, MN; Haiman, CA; Conti, DV; Eeles, RA; Kote-Jarai, Z (2018) Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease. British Journal of Cancer, 119 (1). pp. 96-104. ISSN 0007-0920 https://doi.org/10.1038/s41416-018-0141-7
SGUL Authors: Cieza-Borrella, Clara Isabel

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (643kB) | Preview

Abstract

Background Prostate cancer (PrCa) demonstrates a heterogeneous clinical presentation ranging from largely indolent to lethal. We sought to identify a signature of rare inherited variants that distinguishes between these two extreme phenotypes. Methods We sequenced germline whole exomes from 139 aggressive (metastatic, age of diagnosis < 60) and 141 non-aggressive (low clinical grade, age of diagnosis ≥60) PrCa cases. We conducted rare variant association analyses at gene and gene set levels using SKAT and Bayesian risk index techniques. GO term enrichment analysis was performed for genes with the highest differential burden of rare disruptive variants. Results Protein truncating variants (PTVs) in specific DNA repair genes were significantly overrepresented among patients with the aggressive phenotype, with BRCA2, ATM and NBN the most frequently mutated genes. Differential burden of rare variants was identified between metastatic and non-aggressive cases for several genes implicated in angiogenesis, conferring both deleterious and protective effects. Conclusions Inherited PTVs in several DNA repair genes distinguish aggressive from non-aggressive PrCa cases. Furthermore, inherited variants in genes with roles in angiogenesis may be potential predictors for risk of metastases. If validated in a larger dataset, these findings have potential for future clinical application.

Item Type: Article
Additional Information: Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. © The Author(s) 2018 Correction available at https://doi.org/10.1038/s41416-019-0419-4
Keywords: Oncology & Carcinogenesis, 1112 Oncology and Carcinogenesis
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Academic Structure > Institute of Medical & Biomedical Education (IMBE) > Centre for Biomedical Education (INMEBE)
Journal or Publication Title: British Journal of Cancer
ISSN: 0007-0920
Language: en
Dates:
DateEvent
July 2018Published
19 June 2018Published Online
17 May 2018Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
C5047/A17528Cancer Research UKhttp://dx.doi.org/10.13039/501100000289
P01CA196569National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
R01CA140561National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
R01ES016813National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
R01CA196931National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
U19CA148537National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
URI: https://openaccess.sgul.ac.uk/id/eprint/111859
Publisher's version: https://doi.org/10.1038/s41416-018-0141-7

Actions (login required)

Edit Item Edit Item